Taizhou Fourth People's Hospital
🇨🇳China
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris
Phase 4
- Conditions
- Angina, StableInflammation
- Interventions
- Drug: PlaceboDrug: Dan-shen extractOther: Standard medical care
- First Posted Date
- 2016-08-17
- Last Posted Date
- 2016-09-13
- Lead Sponsor
- Taizhou Fourth People's Hospital
- Target Recruit Count
- 156
- Registration Number
- NCT02870764
- Locations
- 🇨🇳
Taizhou Fourth People's Hospital, Taizhou, Jiangsu, China
News
No news found